Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network : JNCCN
|February 12, 2017
Summary
Multiple myeloma (MM) is a cancer of plasma cells, leading to bone damage and other complications. This article discusses NCCN guidelines for diagnosing and treating newly diagnosed MM.
Area of Science:
- Hematology
- Oncology
Background:
- Multiple myeloma (MM) originates from the abnormal proliferation of plasma cells.
- This neoplastic growth in the bone marrow results in monoclonal immunoglobulin production and characteristic skeletal damage.
- Associated complications encompass hypercalcemia, renal insufficiency, anemia, and increased susceptibility to infections.
Purpose of the Study:
- To present the National Comprehensive Cancer Network (NCCN) guidelines for managing plasma cell dyscrasias.
- To focus on the diagnostic and therapeutic recommendations for patients newly diagnosed with multiple myeloma.
Main Methods:
- Review of NCCN Multiple Myeloma Panel guidelines.
- Synthesis of recommendations for newly diagnosed multiple myeloma.
Main Results:
- Guidelines cover diagnosis and treatment strategies for multiple myeloma.
- Recommendations address management of various plasma cell disorders.
Conclusions:
- The NCCN provides comprehensive guidelines for multiple myeloma management.
- These guidelines aid in the diagnosis and treatment of newly diagnosed multiple myeloma patients.
More Related Videos
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.6K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.9K
Related Concept Videos
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
01:19Standards of Care II
1.2K
Nurses bear specific legal responsibilities under several federal statutes, including:
1.2K
01:26Nephrotic Syndrome II : Assessment and Medical Management
289
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
289
01:15Differentiation of Common Myeloid Progenitor Cells
4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K